BNP Paribas Exane Cuts Procter & Gamble (NYSE:PG) Price Target to $165.00

Procter & Gamble (NYSE:PG) had its price objective trimmed by BNP Paribas Exane from $172.00 to $165.00 in a research report report published on Thursday morning,MarketScreener reports. The firm currently has an outperform rating on the stock.

A number of other analysts have also recently weighed in on PG. Jefferies Financial Group decreased their price target on shares of Procter & Gamble from $179.00 to $175.00 and set a “buy” rating for the company in a research note on Monday, April 20th. Piper Sandler decreased their price target on shares of Procter & Gamble from $150.00 to $142.00 and set a “neutral” rating for the company in a research note on Wednesday, April 8th. TD Cowen decreased their price target on shares of Procter & Gamble from $156.00 to $142.00 and set a “hold” rating for the company in a research note on Wednesday, April 1st. Dbs Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Finally, UBS Group decreased their price target on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research note on Tuesday, April 7th. Ten analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average price target of $160.41.

Procter & Gamble Trading Up 1.6%

Shares of Procter & Gamble stock opened at $148.11 on Thursday. The stock has a market cap of $344.21 billion, a price-to-earnings ratio of 21.94, a PEG ratio of 5.62 and a beta of 0.41. The company has a fifty day simple moving average of $150.32 and a 200-day simple moving average of $148.67. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.49. Procter & Gamble has a 12-month low of $137.62 and a 12-month high of $170.99.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. The firm had revenue of $21.24 billion during the quarter, compared to analysts’ expectations of $21.52 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. Procter & Gamble’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts forecast that Procter & Gamble will post 6.95 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 24th will be paid a $1.0885 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date is Friday, April 24th. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is 64.44%.

Insiders Place Their Bets

In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the completion of the transaction, the insider owned 44,735 shares in the company, valued at $7,259,595.80. This trade represents a 25.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary A. Coombe sold 36,093 shares of the stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the completion of the transaction, the chief executive officer owned 34,994 shares of the company’s stock, valued at $5,680,576.02. This represents a 50.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 252,715 shares of company stock worth $40,966,904. Insiders own 0.20% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

A number of large investors have recently made changes to their positions in PG. Halbert Hargrove Global Advisors LLC purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at about $25,000. E Fund Management Hong Kong Co. Ltd. increased its holdings in shares of Procter & Gamble by 1,000.0% in the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares in the last quarter. Park Square Financial Group LLC increased its holdings in shares of Procter & Gamble by 65.1% in the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock valued at $26,000 after purchasing an additional 71 shares in the last quarter. Evolution Wealth Management Inc. increased its holdings in shares of Procter & Gamble by 1,315.4% in the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after purchasing an additional 171 shares in the last quarter. Finally, Litman Gregory Wealth Management LLC purchased a new position in shares of Procter & Gamble in the 4th quarter valued at about $26,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Q3 earnings and core metrics beat expectations — adjusted EPS topped consensus and net sales/organic sales rose year‑over‑year, showing volume-led growth that suggests improving consumer demand. Business Wire: Q3 Results
• Positive Sentiment: Beauty and premium brands outperformed (e.g., SK‑II growth), supporting higher-margin mix and contributing to market‑share gains cited by management. Reuters: Beauty Demand Strength
• Positive Sentiment: Unusually heavy call-option buying and positive analyst notes pre/post‑release amplified buying momentum, signaling increased bullish positioning from traders and some brokers. (Options volume spike reported in market coverage.)
• Neutral Sentiment: Management reiterated fiscal‑2026 guidance (EPS range ~6.83–7.09) and maintained its outlook — that gives reassurance on the plan but leaves upside capped until guidance is raised. P&G Press Release / Slides
• Negative Sentiment: P&G disclosed a roughly $150 million hit to annual profits from Middle East disruptions (higher energy/logistics/input costs), a tangible near‑term headwind that pressure margins and could constrain FY earnings. Benzinga: $150M Hit
• Negative Sentiment: Some sell‑side desks trimmed price targets and highlighted input-cost risks (resin, energy), which tempers upside and keeps valuation scrutiny on the stock. MarketScreener: PT Adjustments

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.